The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study
Authors
Kevin Schwartzman (ORCID: https://orcid.org/0000-0002-3354-1159)
The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study
Kevin Schwartzman, Monica Shandal, Zaza Avaliani, Inés García Baena et al.
Citations
2 citations
Journal
The Lancet Global Health
Topics
Tuberculosis Research and Epidemiology
Field-Weighted Citation Impact (FWCI)
2.79
article
The effectiveness, cost-effectiveness, budget impact, and return on investment of scaling up tuberculosis screening and preventive treatment in Brazil, Georgia, Kenya, and South Africa: a modelling study
Kevin Schwartzman, Monica Shandal, Zaza Avaliani, Inés García Baena, Maka Danelia, Daniel Mwai, Norbert Ndjeka, Dennis Falzon, Gesine Meyer‐Rath, Nino Lomtadze, Daniele Maria Pelissari, Mmamapudi Kubjane, Nimalan Arinaminpathy, Nelly Solomonia, Elias Joseph Jabbour, Maiko Luís Tonini, Cecily Miller, Immaculate Kathure, Jonathon R. Campbell, Wesley Rotich, Anete Trajman, Júlio Croda, Saskia den Boon, Juan F Vesga, Rhoda Pola, Mona Salaheldin Mohamed, Hlengani Mathema, Fernanda Dockhorn Costa
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Global HealthVol. 13(11)
Institutions
National Center for Disease Control and Public Health (GE), Universidade Federal do Rio de Janeiro (BR), Universidade Federal de Mato Grosso do Sul (BR), University of the Witwatersrand (ZA), World Health Organization (CH), National Center for Tuberculosis and Lung Disease (GE), Ministério da Saúde (BR), McGill University (CA)